Beihai Gofar Marine Biological Industry Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
April 29, 2020 at 11:31 pm IST
Share
Beihai Gofar Marine Biological Industry Co., Ltd. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was CNY 58.873 million compared to CNY 55.592 million a year ago. Operating income was CNY 1.809 million compared to CNY 1.158 million a year ago. Net income was CNY 1.030 million compared to CNY 1.542 million a year ago. Basic earnings per share from continuing operations was CNY 0.0022 compared to CNY 0.0033 a year ago.
Beihai Gofar Chuanshan Biological Co Ltd, formerly Beihai Gofar Marine Biological Industry Co Ltd, is a China-based company mainly engaged in the production and sales of pharmaceutical products and pesticide products. The Company is mainly engaged in the Pharmaceutical Distribution segment, the Pharmaceutical Manufacturing segment, the Deoxyribonucleic Acid Identification and Service segment, and the Other segment. The Company is mainly engaged in pharmaceutical manufacturing and pharmaceutical distribution industries, molecular medical imaging centers, tumor radiotherapy centers, and tumor telemedicine technical services, molecular diagnostics and judicial identification technical services. The Company mainly sells its products in the domestic market.
BEIHAI GOFAR CHUANSHAN BIOLOGICAL CO., LTD. 
